With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
On Monday, the FDA approved iRhythm Technologies, Inc.’s (NASDAQ:IRTC) 510(k) submission related to prior design changes to the Zio AT device via letter to file. Zio AT remains commercially available ...
iRhythm Zio is in many ways a poster child for a connected health company. The company, which makes a peel-and-stick patch for mobile ECG recording, is one of the few wearable medical device companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback